Autophagy-related genes affect the survival of multiple myeloma patients depending on chromosomal abnormality.

The classification of MM patients according to the absence or presence of ABN is important in the determination of survival status. Detection of survival related ARGs in patients with chromosomal anomalies may be a new therapeutic target in treatment.